TSXV/APLI.H (TSXV/APLI.H)

TSX Venture Exchange: TSXV/APLI.H · CAD

CA$0.01

+0.00 (0.0%)· Recorded snapshot

Market cap	661.8K
Revenue (ttm)	362.1K
Net income (ttm)	-4.7M
EPS (ttm)	-CA$0.04
Shares out	132.4M
Volume	106,250
Beta	0.14

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 362.1K
Net income (ttm): -4.7M
EPS (ttm): -CA$0.04
Market cap: 661.8K

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROEn/a

P25 -104.1P50 -30P75 6.7

ROICn/a

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All TSXV/APLI.H indicators

Market & fundamental data

Available fields

159

Groups with data

Currency

CAD

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-27
Employees	7
Employees change	0
Employees growth	0%
Enterprise value	CAD 13.8M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-10-10
Fiscal year end	March
Founded	2015
Industry	Medical - Pharmaceuticals
Is primary listing	Yes
ISIN number	CA03783R1073
Last refreshed	2026-10-28
Market cap	CAD 661,831
Next earnings date	2026-11-27
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	tsxv/APLI.H
Website	https://appilitherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-741.62%
EV/Sales	38.25x
FCF / EV yield	-9.88%
FCF yield	-206.7%
P/S ratio	1.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Operating margin	-1,804.94%
Pretax margin	-1,272.94%
Profit per employee	CAD -670,089
Revenue per employee	CAD 51,725
ROA	-255.65%
ROA (5Y)	-172.39%
ROCE	35.55%
SBC / revenue	11%
Tax / revenue	22.55%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	260.48%
Gross profit growth 3Y	2.71%
Revenue growth	260.48%
Revenue growth (QoQ)	366.67%
Revenue growth 3Y	2.71%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	CAD 5,820
EBIT	CAD -6.5M
EBITDA	CAD -6.5M
EPS	CAD -0.04
FCF per share	CAD -0.01
Financing cash flow	CAD 363,932
Free cash flow	CAD -1.4M
Free cash flow minus SBC	CAD -1.4M
Gross profit	CAD 362,073
Income taxes	CAD 81,663
Net borrowing	CAD -32,580
Net cash flow	CAD -986,369
Net income	CAD -4.7M
Operating cash flow minus SBC	CAD -1.4M
Operating income	CAD -6.5M
Revenue	CAD 362,073
Stock-based compensation	CAD 39,834

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-117.28
Book value per share	CAD -0.14
Interest coverage	-4.41
Long-term assets	CAD 9,608
Long-term liabilities	CAD 640,300
Net cash (debt)	CAD -13.2M
Net cash / market cap	-1,992.59%
Piotroski F-Score	3
Property, plant and equipment	CAD 9,608
Shareholders' equity	CAD -19M
Tangible book value	CAD -19M
Tangible book value per share	CAD -0.14
Total assets	CAD 1.3M
Total cash	CAD 138,680
Total debt	CAD 13.3M
Total liabilities	CAD 20.3M
WACC	8.61%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.23
Current assets	CAD 1.3M
Current liabilities	CAD 19.7M
Current ratio	0.07
Net working capital	CAD -5.8M
Quick ratio	0.06
Working capital	CAD -18.4M
Working capital turnover	-0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-4.31%
Shareholder yield	-4.31%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.02
1D price change	0%
1M price change	-50%
1M total return	-50%
1Y price change	-83.33%
1Y return CAGR	-83.35%
1Y total return	-83.33%
20-day SMA	CAD 0.01
200-day SMA	CAD 0.02
3M price change	-50%
3M total return	-50%
3Y price change	-87.5%
3Y return CAGR	-49.99%
3Y total return	-87.5%
50-day SMA	CAD 0.01
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.03
52-week high date	2025-12-08
52-week low	CAD 0.01
52-week low date	2026-10-28
5Y price change	-99.35%
5Y return CAGR	-63.49%
5Y total return	-99.35%
6M price change	-75%
6M total return	-75%
All-time high	CAD 1.89
All-time high date	2020-05-19
All-time low	CAD 0.01
All-time low date	2026-10-06
Average true range (ATR)	CAD 0.00
Average volume	102.5K
Beta (1Y)	-3.49
Beta (2Y)	-0.6
Beta (5Y)	0.14
Change from 52-week high	-83.33%
Change from 52-week low	0%
Change from all-time high	-99.74%
Change from all-time low	0%
Change from open	-50%
Day's gap	100%
Dollar volume	CAD 531
High price	CAD 0.01
Low price	CAD 0.01
Monthly RSI	31.28
Open price	CAD 0.01
Position in 52-week range	0%
Previous close	CAD 0.01
Price vs 150-day SMA	-71.59%
Price vs 20-day SMA	-42.53%
Price vs 200-day SMA	-73.26%
Price vs 50-day SMA	-56.14%
Relative volume	1.04
RSI	36.3
Sharpe ratio	0.83
Sharpe ratio (3Y)	0.66
Sharpe ratio (5Y)	0.27
Sortino ratio	1.53
Sortino ratio (3Y)	1.18
Sortino ratio (5Y)	0.49
Volume	106.3K
Weekly RSI	33.36
YTD price change	-80%
YTD total return	-80%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	117.9M
Shares change (QoQ)	20.58%
Shares change (YoY)	4.31%
Shares held by insiders	0.06%
Shares outstanding	132.4M

Deeper analysis on TSXV/APLI.H

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/APLI.H report

Is a complete TSXV/APLI.H research report available?

No complete published report is available for tsxv/APLI.H (TSXV/APLI.H) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/APLI.H (TSXV/APLI.H)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/APLI.H

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/APLI.H indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/APLI.H

Frequently asked questions